Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 99
Filtrar
1.
Pharmacopsychiatry ; 57(2): 78-81, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38471512

RESUMO

Antipsychotics can cause hematologic disorders, and they can have life-threatening consequences. Risperidone, less commonly associated with hematologic adverse effects, is an atypical antipsychotic medication used to treat conditions such as schizophrenia, bipolar disorder and irritability associated with autism. While risperidone primarily affects the central nervous system, it can have some hematologic adverse effects, although these are relatively rare. It is crucial to note that these side effects are not common, and most people taking risperidone do not experience hematologic disorders. The reporting of such disorders may be more frequent with clozapine compared to other atypical antipsychotics because clozapine treatment necessitates regular hematological monitoring 1.


Assuntos
Antipsicóticos , Clozapina , Humanos , Risperidona/efeitos adversos , Clozapina/uso terapêutico , Olanzapina , Benzodiazepinas/efeitos adversos , Antipsicóticos/uso terapêutico
2.
Hosp Pharm ; 59(2): 146-148, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38450348

RESUMO

Hiccups, also called hiccoughs, are sudden, involuntary and rapid expulsion of air from the lungs with synchronous closure of the glottis causing blockade of the air flow. Hiccups may be induced by a multitude of etiologies such as central nervous disorders, gastrointestinal disorders, cardiovascular disorders, psychogenic factors, and metabolic disorders. Hiccups induced by medications are rare. The diagnosis of drug-induced hiccup is difficult. The exact mechanism responsible for this adverse drug reaction is still unknown. Herein, we report the first case of cefotaxime-induced hiccups and briefly review the literature on antibiotic-induced hiccups.

3.
N Engl J Med ; 385(4): 383, 2021 Jul 22.
Artigo em Inglês | MEDLINE | ID: mdl-34289292
5.
11.
J Neurogenet ; 30(1): 16-21, 2016 03.
Artigo em Inglês | MEDLINE | ID: mdl-27276192

RESUMO

The aim of this study was to evaluate the impact of polymorphisms in the EPHX1 (c.416A > G, c.337T > C) and CYP3A4*22 genes involved in carbamazepine (CBZ) metabolism and pharmacoresistance among 118 Tunisian patients with epilepsy under maintenance dose of CBZ. These genetic polymorphisms were analyzed by PCR-RFLP. Associations between plasma CBZ concentration, CBZ-E concentration, maintenance doses and metabolic ratio (CBZ-E:CBZ, CBZ-D:CBZ-E) were analyzed with each polymorphism. Both variants of EPHX1 c.416A > G and c.337T > C are significantly associated with higher metabolic ratio CBZ-E:CBZ and seem to decrease the activity of the epoxide hydrolase. The CYP3A4*22 variant allele is significantly associated with lower CBZ-D:CBZ-E ratio and seems also to be associated with less activity of the cytochrome. Our data suggest that certain polymorphisms of metabolizing enzyme genes could influence inter-individual variability of CBZ metabolism.


Assuntos
Anticonvulsivantes/metabolismo , Carbamazepina/metabolismo , Citocromo P-450 CYP3A/genética , Resistência a Medicamentos/genética , Epilepsia/tratamento farmacológico , Epóxido Hidrolases/genética , Adulto , Anticonvulsivantes/uso terapêutico , Carbamazepina/uso terapêutico , Epilepsia/genética , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Polimorfismo de Nucleotídeo Único , Tunísia
16.
N Engl J Med ; 377(19): 1904, 2017 11 09.
Artigo em Inglês | MEDLINE | ID: mdl-29120142
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA